Natasha Onalenna Moraka is currently pursuing her Masters in Medical Virology at Stellenbosch University in South Africa. She holds a BSc in Biology and Chemistry from University of Botswana. Her main areas of interest are within virology, immunology and molecular biology of HIV and HIV co-infections; such as CMV, TB and HPV, with particular interest in the paediatric population. She has worked on a few independent research projects looking into the impact of HIV and CMV co-infection on pregnancy, infant neurodevelopmental outcomes, as well as infant growth outcomes.
Currently Moraka is working on a project that aims at assessing the impact of HIV drug resistance (HIVDR) and broadly neutralising antibody (bNab) escape mutations on treatment options for recently perinatally HIV infected children in Botswana and South Africa; countries with high prevention of mother to child (PMTCT) coverage.